Provista Diagnostics Receives $2,564,948 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=57ddd2ea-2500-4d58-84de-ecc0a828d803
Date
10/28/2016
Company Name
Provista Diagnostics
Mailing Address
55 Broad Street 18th Floor New York, NY 10004 USA
Company Description
Provista Diagnostics, Inc. develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes.
Website
http://www.provistadx.com
Transaction Type
Venture Equity, Debt
Transaction Amount
$2,564,948
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed